Watchdog Urges HHS to Investigate Conflicts Among FDA's Peptide Panelists
(MedPage Today) -- A consumer watchdog group is demanding that the HHS Office of Inspector General (OIG) look into potential conflicts of interest among members of an FDA advisory committee that recommended that six peptides be added to the list...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.